"Live" updates from the conference if you can't call in.

Aboveallislove

Super Moderator
16 specialists from Vertex across u.s. and ready to discuss with doctors.
Vertex Guidance and Patient Support: Help to get drugs to patients i.e. work with insurance, navigate insurance process.
Price: $259,000.

From press release that is key: "The efficacy and safety of ORKAMBI have not been established in patients with CF other than those homozygous for the F508del mutation." Doesn't say IT DOESN'T work, LIKE kALYDECO LABEL DID.
 

Aboveallislove

Super Moderator
Additional studies for 6-11 in EU are about to start. In U.S. fully enrolled. Said results "next year" but clinicaltrials.gov says October.
 
Top